Moorfields Eye Hospital to sell Moorfields Pharmaceuticals to Rayner Pharmaceuticals Limited

Moorfields Eye Hospital NHS Foundation Trust has announced today that it has sold its commercial pharmaceutical business, Moorfields Pharmaceuticals, to the ophthalmic manufacturer, Rayner Pharmaceuticals Limited

This announcement follows a strategic review by Moorfields Eye Hospital and the businesses within its portfolio. Staff currently employed by Moorfields Pharmaceuticals will transfer to Rayner however they will continue to be based in London and will shortly be moving to a new office.

Rayner is a British company and the only manufacturer of intraocular lenses in the UK.

Rayner has been operating for over 100 years and currently sells to more than 80 countries around the world.

David Probert, chief executive of Moorfields Eye Hospital NHS Foundation Trust, said: “Following a detailed strategic review, we have taken the decision to sell Moorfields Pharmaceuticals. We believe Rayner will enable the pharmaceutical business to grow and ensure that its products are available for many years to come.”

Tim Clover, Rayner CEO, said: “We are committed to supporting ophthalmologists in attaining the best outcomes for their patients. Although the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result.  For that reason, the acquisition of Moorfields Pharmaceuticals will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient. We are delighted to welcome Moorfields Pharmaceuticals to the Rayner team.”

Alan Krol, managing director of Moorfields Pharmaceuticals, said: “Both Moorfields Pharmaceuticals and Rayner have a long and distinguished history in providing innovation, customer choice and value to the eye care community. Together we will be able to deliver existing and new products to our customers which will improve the care of patients. We are delighted to be joining forces with Rayner.”

Was this information useful? Please rate the page.